Director Amnon Peled resigns from Silexion Therapeutics board effective August 1, 2026

Silexion Therapeutics Corp

Professor Amnon Peled resigned from the Board of Directors for personal reasons, effective August 1, 2026.
Resignation did not result from any disagreement with the Company on operations, policies, or practices.
No replacement director has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Amnon Peled

Director

SLXN · Silexion Therapeutics Corp

Effective: 2026-08-01
Filed: July 31, 2026, 4:06 PM ET

On July 30, 2026, Professor Amnon Peled notified the Board of Directors (the “ Board ”) of Silexion Therapeutics Corp (the “ Company ”) of his resignation from his position as a member of the Board, for personal reasons, effective as of August 1, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Amnon Peled resigned as Director at Silexion Therapeutics Corp.

Action: resigned
Role: Director

Exact text from the filing

On July 30, 2026, Professor Amnon Peled notified the Board of Directors (the “ Board ”) of Silexion Therapeutics Corp (the “ Company ”) of his resignation from his position as a member of the Board, for personal reasons, effective as of August 1, 2026.

View on SEC.gov

Silexion Therapeutics Corp filing history →

Source: SEC EDGAR

accession 0001178913-26-003742

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.